- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03162679
Culture-sensitive Emotion Regulation Group Therapy for Traumatized Refugees
April 2, 2019 updated by: Theresa Koch, Ludwig-Maximilians - University of Munich
Culture-sensitive Emotion Regulation Group Therapy for Traumatized Refugees: A Randomized Controlled Trial
There is a lack of studies on treatment effect in traumatised refugees.
Recent findings indicate that emotion regulation deficits play a key role in PTSD also among traumatized refugees and highlight the importance and potential directions for the development of an emotion regulation training for refugees.
In this study, the investigators therefore want to examine the effectiveness of a new, transdiagnostic, cultural-sensitive group therapy, which systematically teaches specific emotion regulation strategies.
Participants will be randomly assigned to either the emotion regulation training, delivered in group format or a wait list control condition.
The study takes place in cooperation with REFUGIO Munich, which is a treatment centre specialised in the treatment of traumatised refugees.
Clinicians will deliver the treatment to traumatized asylum seekers and refugees that report difficulties in emotion regulation.
The investigators will examine if refugees and asylum seekers in the intervention group will show improvements in psychological symptoms, social functioning as well as in emotion regulation in comparison to a wait list control group which will receive the treatment after the intervention group has completed.
The group therapy covers 14 sessions and has a cognitive-behavioural background.
It focuses on conveying strategies to cope with intense feelings and the patients should gain a sense of self-efficacy and control over their trauma-relevant feelings and symptoms.
Qualified interpreters will be used in the assessments as well as group therapies.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
44
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Munich, Germany
- REFUGIO München
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
15 years to 21 years (Child, Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Male
Description
Inclusion Criteria:
- Refugee or asylum seeker from Afghanistan, speaking Dari
- reporting at least one traumatic event on a trauma list
- reporting difficulties in emotion regulation
- between the age of 15 and 21 years
Exclusion Criteria:
- Psychosis
- Serious suicidal ideations
- Currently receiving psychotherapy elsewhere
- Serious dissociation
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Emotion Regulation Group Therapy
Participants assigned to this condition will receive treatment immediately after assignment.
|
Emotion Regulation Group Therapy, 14 sessions, 1.5 hour sessions, group therapy, meeting weekly.
Other Names:
|
No Intervention: Wait List Control
This condition is a wait-list control and receives no intervention during the study period, but is offered treatment after the final assessment directly after the treatment phase of the intervention group.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Difficulties in Emotion Regulation
Time Frame: baseline, after 14 weeks (= post-treatment), 3-months-follow-up (3 months after the treatment)
|
Scale: Emotion Regulation Scale (DERS)
|
baseline, after 14 weeks (= post-treatment), 3-months-follow-up (3 months after the treatment)
|
Change in General Health
Time Frame: baseline, after 14 weeks (= post-treatment), 3-months-follow-up (3 months after the treatment)
|
Scale General Health Questionnaire -28 (GHQ-28)
|
baseline, after 14 weeks (= post-treatment), 3-months-follow-up (3 months after the treatment)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in posttraumatic stress
Time Frame: baseline, after 14 weeks (= post-treatment), 3-months-follow-up (3 months after the treatment)
|
Scale: PTSD Checklist for DSM-5 (PCL-5)
|
baseline, after 14 weeks (= post-treatment), 3-months-follow-up (3 months after the treatment)
|
Change in Anger Reactions
Time Frame: baseline, after 14 weeks (= post-treatment), 3-months-follow-up (3 months after the treatment)
|
Scale: Dimensions of Anger Reactions-5 (DAR-5)
|
baseline, after 14 weeks (= post-treatment), 3-months-follow-up (3 months after the treatment)
|
Treatment Experience Scale - Patient (TESP)
Time Frame: after 14 weeks (= post-treatment)
|
after 14 weeks (= post-treatment)
|
|
Change in emotional competence (Third party assessment by caregiver)
Time Frame: baseline, after 14 weeks (= post-treatment), 3-months-follow-up (3 months after the treatment)
|
Scale: Emotional Competence Questionnaire (German: Emotionale-Kompetenz-Fragebogen - Fremdbeurteilung (EKF))
|
baseline, after 14 weeks (= post-treatment), 3-months-follow-up (3 months after the treatment)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Alexandra Liedl, PhD, REFUGIO München
- Study Director: Theresa Koch, M.Sc., Ludwig-Maximilians-Universität München/ REFUGIO München
- Study Chair: Thomas Ehring, Professor, Ludwig-Maximilians-Universität München
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 1, 2017
Primary Completion (Actual)
December 21, 2018
Study Completion (Actual)
February 1, 2019
Study Registration Dates
First Submitted
May 18, 2017
First Submitted That Met QC Criteria
May 19, 2017
First Posted (Actual)
May 22, 2017
Study Record Updates
Last Update Posted (Actual)
April 3, 2019
Last Update Submitted That Met QC Criteria
April 2, 2019
Last Verified
April 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 022ERT
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Trauma
-
Humacyte, Inc.Active, not recruitingTrauma | Trauma Injury | Trauma, Multiple | Trauma BluntUkraine
-
Prof. Dr. Cemil Tascıoglu Education and Research...CompletedTrauma Injury | Trauma, MultipleTurkey
-
University Hospital, AngersRecruiting
-
Wonju Severance Christian HospitalNational Research Foundation of KoreaRecruitingTrauma Injury | Trauma, MultipleKorea, Republic of
-
Rabin Medical CenterIsraeli Ministry of SecurityUnknown
-
Oslo University HospitalUniversity of Oslo; Sunnaas Rehabilitation Hospital; South-Eastern Norway Regional...RecruitingTrauma Injury | Trauma, Multiple | PolytraumaNorway
-
Chang, Steve S., M.D.Santa Barbara Cottage Hospital; Accumetrics, Inc.CompletedHead Injury Trauma BluntUnited States
-
Assistance Publique - Hôpitaux de ParisFrancophone Pediatric Resuscitation and Emergency Group (GFRUP)Completed
-
Fundacion Clinica Valle del LiliUniversity of Pittsburgh; Hospital Universitario del Valle Evaristo GarciaRecruitingTrauma | Trauma Injury | Trauma, MultipleColombia
Clinical Trials on Skills training of Affect-Regulation - A culture-sensitive approach: STARK
-
Seattle Children's HospitalNational Institute on Drug Abuse (NIDA); University of Washington; Michigan State... and other collaboratorsRecruiting